Walk out of your doctor's office and try to recall everything that was discussed. Chances are you'll remember less than half—a problem that's been documented for decades but has resisted easy technological fixes until now.
That gap in medical memory is the bet behind Kin Health, a Los Angeles startup that just closed a $9 million seed round, announced in May 2026, with backing that reads like a reunion of GoodRx's founding team. The company's pitch is deceptively simple: record your doctor visits on your phone, then let AI translate the medical jargon into plain language summaries you can actually understand and act on.
Doug Hirsch and Trevor Bezdek, who co-founded prescription drug pricing giant GoodRx, have joined Kin not merely as investors but as founding partners and executive chairmen—a level of involvement that suggests they see echoes of their earlier success. The connection runs deeper still. Kyle Alwyn, one of Kin's three co-founders, previously built HeyDoctor, a telehealth service that GoodRx snapped up in 2019.
The Forgetfulness Problem, Quantified
The clinical evidence underpinning Kin's thesis is sobering. A 2018 study published in PLOS ONE found patients accurately recalled just 49% of clinical decisions and recommendations without prompting. Other research shows roughly half of hospital patients forget critical discharge instructions. Some older studies—still referenced by the Agency for Healthcare Research and Quality—put the forgetting rate somewhere between 40% and 80%.
Given that Americans made roughly 1 billion office visits to physicians in 2019, according to the last comprehensive CDC data before the pandemic upended everything, the scale of the problem is hard to dismiss. Even a modest improvement in recall could ripple across millions of encounters.
"Patients are overwhelmed," said Natalie Dillon, the Maveron partner who led the investment. Her firm was joined by Town Hall Ventures, Flex Capital, Eniac Ventures, The Family Fund, Pear VC, Watershed Ventures, and Foundry Square Capital. The round attracted more than 30 physicians as individual backers—an unusual level of clinician interest for a consumer health app.
A Consumer Play in a Crowded Field
Kin's iOS and Android apps, both free to patients, let users record in-person or telehealth appointments. The AI-generated summaries break down medical terminology and outline next steps—think of it as having a translator in your pocket for doctor-speak. The app launched on Apple's App Store in April and carries a 4.8-star rating across 114 reviews, though that sample size is still modest.
The company plans to make money not from patients but through referrals—connecting users to specialists, labs, and prescription services, following the revenue model the company has described. It's a page straight from the GoodRx playbook, which turned free drug price comparisons into a referral engine worth billions at its IPO peak.
What sets Kin apart, perhaps, is its insistence on staying patient-side. Unlike most ambient AI tools, which integrate into electronic health records and serve clinicians, Kin requires no EHR hookup. The company says it's not a HIPAA covered entity because patients use it independently for personal purposes; data is encrypted, and users control what gets shared.
That independence is both a feature and a constraint. Kin won't automate physician documentation—a lucrative market that's become intensely competitive.
Navigating the Ambient AI Land Grab
The timing is tricky. Ambient AI for healthcare has become one of the sector's hottest categories, with capital pouring in and established players racing to expand. Abridge, which won Best in KLAS awards for Ambient AI in both 2025 and 2026, added patient-facing summaries last year. Freed pulled in a $30 million Series A led by Sequoia just last month. Heidi Health closed a $65 million Series B back in October.
Most of those companies focus on the provider side—reducing documentation burden for overstretched clinicians. Kin is placing a different bet: that consumers will adopt the tool themselves, creating a direct relationship that could eventually extend into care navigation and decision support.
Earlier attempts at patient-side recording tools have had mixed results. Medcorder raised $2.5 million in 2019 but hasn't achieved breakout scale. Whether Kin can avoid that fate may come down to distribution—and this is where the GoodRx pedigree becomes crucial.
The Team Behind the Tech
The founding trio brings an unusual mix of clinical depth and startup velocity. Arpan Parikh and Amit Parikh are both double board-certified psychiatrists who previously served as chief medical officers at SOL Mental Health and Bend Health, respectively. Alwyn, the technical co-founder, handles the engineering side. The company launched in summer 2025 and by July had grown to roughly 22 employees, according to LinkedIn data.
The seed funding, which came in oversubscribed, will expand the consumer product and deepen health record integration capabilities—a notable pivot given the company's current no-EHR-required stance. Kin also plans to build what it calls a "clinical quality and rigor engine," though details remain scarce. Later this year, the company expects to roll out downstream care navigation features, transforming the app from passive recorder to active guide.
A Familiar Playbook, Different Domain
Whether Kin can replicate GoodRx's trajectory—turning a free consumer tool into a referral juggernaut—remains an open question. The markets are different: prescription pricing information versus post-visit care guidance. But the fundamentals are similar: identify a painful consumer problem, build trust through a free offering, then monetize the relationship through high-intent referrals.
The 49% recall rate offers a stark target. If Kin can move that number meaningfully higher, the business case may follow. If not, it'll join the long list of well-funded health tech ideas that made intuitive sense but couldn't crack consumer adoption at scale.
For now, the GoodRx founders are betting their reputations—and their capital—that patients are ready to bring a digital scribe into the exam room.
